OpenAlex
PricingAboutJobs
Log inGet started
Work

Cladribine: Mode of Action and Implications for Treatment of Multiple Sclerosis

HTML

Year: 2011
Type: review
Source: Clinical Neuropharmacology
DOI: 10.1097/wnf.0b013e318204cd90
Authors: Thomas P. Leist, Robert Weissert
Institutions: Thomas Jefferson University, University Hospital of Geneva, Merck Serono S.A. (Switzerland)
Language: English

Topic: Multiple Sclerosis Research Studies
Subfield: Clinical Neurology
Field: Medicine
Domain: Health Sciences
Keywords: cladribine, multiple sclerosis, relapsing-remitting multiple sclerosis, mechanism of action, deoxycytidine kinase, DNA synthesis inhibition, DNA strand breaks, lymphocyte depletion, demyelination, CLARITY trial, neuroimaging findings
SDG: Good health and well-being

Open Access status: closed

Funder: Merck KGaA
OpenAlex ID: W2016149155
FWCI: 0.861
Cites: 72
Cited by: 227
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms